In general, the adiponectin concentration decreased in the population with metabolic risks, particularly those related to the waist-to-height index, hypoalphalipoproteinemia, and abdominal obesity, which is consistent with the literature [14,46,47]. The gene discussed is ADIPOQ; the disease is Abdominal obesity.